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We performed studies on murine models and human volunteers to examine the immunoen-
hancing effects of the naturally outdoor-cultivated fruit body of Agaricus brasiliensis KA21
(i.e. Agaricus blazei). Antitumor, leukocyte-enhancing, hepatopathy-alleviating and endotoxin
shock-alleviating effects were found in mice. In the human study, percentage body fat,
percentage visceral fat, blood cholesterol level and blood glucose level were decreased, and
natural killer cell activity was increased. Taken together, the results strongly suggest that the
A. brasiliensis fruit body is useful as a health-promoting food.
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Alternative medicine is the general term for ‘medicine and
treatment that have not been verified scientifically or
applied clinically in modern Western medicine’ (1–12).
The range of alternative medicine varies widely to include
traditional medicine and folk remedies as well as new
therapies that are not covered by health insurance.
Considering the current world population, the percentage
of people utilizing modern Western medicine is surpris-
ingly low, with the World Health Organization (WHO)
indicating that 65–80% of health management is by
traditional medicine. ‘Mibyou’ is a recently established
term that means a half-sick person having clinical
laboratory data that borders healthy individuals and
patients. Education of the mibyou population about
eating habits is also significantly important for maintain-
ing public health by the government.
In Japan, an increasing number of people are turning to
alternative medicine mainly in the form of health foods
such as amino acids, lipids, carbohydrates, plants,
seaweeds, insects, bacteria, yeasts and mushrooms. Such
mushrooms as Lentinula edodes, Ganoderma lucidum and
Grifola frondosa are commercially available. Agaricus
brasiliensis (A. blazei ss. Heinemann) is a health food that
has received recent attention. A. brasiliensis has been
reported to improve symptoms of lifestyle-related diseases
including obesity, hypertension and diabetes, and to have
anti-inflammatory, antitumor, cancer inhibitory and
immuno-enhancing effects (13–18). However, many
reports were either animal studies or clinical studies
with few cases.
Many mushrooms, also called as macrofungi, are clas-
sified as higher-order microorganisms, Basidiomycota.
To discuss the functions of Basidiomycota, it is important
to compare them under the same conditions, including
not only the species but also the strain, as well as
methods of cultivation and processing. Basidiomycota
products involve mycelia, spores and fruit bodies in
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properly cited.each species. The fruit body and the mycelium are
distributed widely in foods. To maintain the manufactur-
ing process, the mycelium is superior to the fruit body;
however, its components are known to be quite different.
There are many ways to obtain the fruit body, e.g.
collecting naturally grown mushrooms from hills and
fields, and outdoor or indoor cultivation.
Agaricus brasiliensis KA21 used in this study is a fruit
body cultivated outdoors in Brazil. Fruit bodies were air
dried by a ventilator with a blowing temperature lower
than 60 C to maintain their enzyme activities. We have
recently examined the structure and antitumor activity
of polysaccharide fractions of the fruit body and
concluded significant contribution of the highly branched
1,3-b-glucan moiety on the activity. We also prepared the
cold and the hot water extracts (AgCWE and AgHWE)
and examined on a murine diabetic model C57Bl Ksj-db/
db, and found that AgCWE showed much stronger
pharmacological activity to this model. These facts
strongly suggested that pharmacological action of cold
water extract differ from that of hot water extract. We
have also shown that the cold water extract contains
enzymes such as polyphenol oxidase and peroxidase
(19–25). Table 1 shows the general constituents of
A. brasiliensis KA21. KA21 has high protein and fiber
content. It also has high levels of vitamins B1, B2, B6,
niacin, pantothenic acid, folic acid and biotin. It contains
many minerals including large amounts of iron, potas-
sium, phosphorus, magnesium, zinc and copper, and
certain amounts of manganese and selenium. In addition,
it contains detectable concentrations of vitamin D as it is
cultivated under the sunlight.
To successfully achieve and maintain food safety for
citizens, laws related to foods have become strictly
controlled. Recently, medical doctors in National Cancer
Center Hospital East in Japan reported three cases of
severe hepatic damage, taking A. blazei extract (26). They
mentioned it is necessary to evaluate many modes of
complementary and alternative medicines, including the
A. blazei extract, in rigorous, scientifically designed and
peer-reviewed clinical trials. Very recently we have
experienced evacuation of one health food originated
from A. brazei, because of inducing genotoxicity in experi-
mental animals. Ministry of Health, Labor and Welfare
reported it is only the case of one product and the
molecular mechanisms are under investigation. It is also
simultaneously reported that other related products did
not show such toxicity. Agaritine is a well known toxic
metabolite of agaricaceae, such as Agaricus bisporus,a n d
the relationship between agaritine content and the toxicity
has attracted attention. In any case, function as well as
safety of products originated from macrofungi, especially
agaricaceae should be precisely examined as much as
possible.
Thus, to safely and effectively use alternative medicine
including A. brasiliensis, analysis at the molecular level
by basic research and proving their effects by clinical
research are important. In a human safety study,
we found that long-term intake of the fruit bodies of
A. brasiliensis KA21 cultivated outdoors had no adverse
effects (22). In the present study, we demonstrated the
immunomodulating effect of A. brasiliensis KA21 both
by animal and human studies. As described earlier,
the fruit body contained many enzymes even after
the drying process, and cold and hot water extracts
were prepared and administered orally to examine
Table 1. Composition of A. brasiliensis KA21
Energy 288.00kcal
Protein 38.50g
Fat 2.60g
Carbohydrate 27.70g
b-glucan 12.4g
Fiber 20.60g
Sodium 8.40mg
Calcium 22.50mg
Iron 10.10mg
Potassium 2920.00mg
Phosphorus 952.00mg
Magnesium 96.50mg
Zinc 7.87mg
Copper 7.67mg
Manganese 0.825mg
Iodine 0
Selenium 88.00mg
Arsenicum 0.48ppm
Cadmium 2.01ppm
Plumbum 0.13ppm
Hydrargyrum 0.18ppm
Total chromium 0mg
Vitamin in A (total caronene) 0
Vitamin B (total caronene)
Vitamin B1 (Thiamin) 0.63mg
Vitamin B2 (Riboflavin) 3.04mg
Vitamin B6 0.54mg
Vitamin B12 0mg
Niacin 33.50mg
Pantothenic acid 22.90mg
Folic acid 230.00mg
Biotin 123.00mg
Total vitamin C (Total c acid) 0mg
Vitamin D 56.7mg
Vitamin E (Total tocopherol) 0
Vitamin K1 loquinone) 0
Agaritine 15.3ppm
Note: In 100g dry weight, measured by Japan Food Research
laboratories.
Agaritine was measured by MASIS laboratories by HPLC method.
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water extracts of A. brasiliensis is a traditional custom in
Brazil. In the clinical study, we determined the weight,
body mass index (BMI), percentage body fat, percentage
visceral fat and blood biochemical levels [total protein,
blood glucose, cholesterol, neutral fat, glutamate oxalo-
acetate transaminase (GOT), glutamate pyrvic transami-
nase (GPT) and glutamyl transferase (g-GTP)], and
natural killer (NK) cell activity before and after admin-
istration of A. brasiliensis KA21. Analysis of the data
from the viewpoint of mibyou is also included.
Methods
Agaricus brasiliensis Fruit Bodies
Strain KA21 was cultivated outdoors in Brazil, and its
fruit bodies were washed and dried using hot air at 60 C
or lower.
Measurement of Ingredients
All ingredients except for agaritine were measured by
Japan Food Research Laboratories, Shibuya, Tokyo
using the standard protocols recommended by the
Resources Council, the Science and Technology Agency
of Japan. The concentration of agaritine was measured
by HPLC/MS/MS by MASIS Inc, Minamitusgaru,
Aomori.
Preparation of Hot Water Extract (AgHWE) and Cold
Water Extract (AgCWE) of A. brasiliensis
The fruit bodies of KA21 (100g each) were ground
using a domestic coffee mill, suspended in 0.1g/ml
physiological saline (Otsuka Pharmaceutical Co., Ltd),
and extracted in an autoclave (120 C, 20min) or with
cold water (4 C, 1day). The supernatant after centrifuga-
tion was designated as AgHWE or AgCWE. The extracts
were kept frozen at  20 C until use.
Oral Administration to Mice
AgHWE and AgCWE prepared by the earlier-described
method were administered to mice orally for 2 weeks, and
cell count and cell population were determined.
Murine Tumor Model
Solid form tumor: Sarcoma 180 cells (1 10
6/mouse)
were subcutaneously administered to the groin of ICR
mice on day 0. AgHWE or AgCWE was orally
administered (p.o.) daily for 35 days. Standard
b-glucan, sonifilan (SPG) was administered intraperito-
neally on days 7, 9 and 11. After 35 days, the mice were
sacrificed and the weight of the solid tumor was
measured.
Inflammatory Cytokine Production in Primed Mice
Balb/c mice were primed with a standard b-glucan, SCG
(200mg/mouse) from Sparassis crispa on day 0, and
AgHWE or AgCWE was orally administered daily for
1 week. One week later, bacterial lipopolysaccharide
(LPS, 10mg/mouse) was administered intravenously,
serum was collected 90min after the LPS administration,
and serum TNF-a and IL-6 expression levels were
measured with ELISA. Antibodies and standards were
purchased from Pharmingen Ltd.
Concanavalin A-Induced Hepatic Injury in Mice
AgHWE or AgCWE were orally administered for several
days in mice. One day after the final administration,
Concanavalin A (Con A) was intravenously administered
to induce liver injury. Interleukin 6 levels in sera were
measured 3h after Con A administration. GOT and GPT
were measured 24h after Con A administration.
Clinical Research in Humans
Research was performed on 31 healthy subjects who were
not taking any medication prior to or at the time of the
study. We explained the study to them in writing, and
obtained informed consent to use the test results. The
subjects were divided into three groups, group 2 and
group 3 (total 20 subjects) were administered the
normal dose, and group 1 (11 subjects) were administered
a 3-fold higher dose (safety clinical study group) of
A. brasiliensis.
Group 1. For 6 months from May 31 to November 26,
2004, the 11 subjects (mean age 43.6 12.6 years, male 6,
female 5) were asked to take 30 tablets/day (divided into
three administrations; each tablet contained 300mg of
A. brasiliensis), which is three times the normal dose.
Then, we measured and analyzed the subjective changes
in their condition, liver function (GOT, GPT, g-GTP),
renal function [blood urea nitrogen (BUN), creatinine]
and nutritional status (total protein).
Group 2. For 3 months from April 12 to July 8, 2005,
12 subjects (mean age 45.3 8.1 years, male 9, female 3)
were asked to take the normal dose of 10 tablets/day
(divided into two administrations; each tablet contained
300mg of A. brasiliensis). Then, we measured body
weight, BMI, percentage body fat, percentage visceral fat
and blood biochemical levels (total protein, blood
glucose, cholesterol, neutral fat, GOT, GPT and g-GTP).
Group 3. For 3 months from May to August, 2005,
8 subjects (mean age 22.3 0.5 years, male 6, female 2)
were asked to take the normal dose, and immune
function (NK cell count, NK cell activity) was measured.
In the measurement of immune function, we divided the
eight subjects into two groups in a double-blind manner,
A. brasiliensis group and placebo group, administered
eCAM 2008;5(2) 20710 tablets/day (divided into two administrations; each
tablet contained 300mg of A. brasiliensis) for 7 days, and
determined NK cell count and NK cell activity in
peripheral blood. After two-month drug withdrawal,
the same study was conducted with the tablets exchanged
(crossover). We analyzed the cell fraction in peripheral
blood and regarded mononuclear cells with
CD3
 CD16
þCD56
þ as NK cells. Following the usual
method, we measured NK cell activity by 4h
51Cr-release
assay using K562 tumor cells as targets, at an effector/
target ratio (E/T)¼20 or 10 (the mixing ratio of
mononuclear cells and K562 cells is 20 or 10).
Statistical Analysis
Paired t-test was used to evaluate statistical significance.
P50.05 was considered significant in all analyses.
Results
Chemical Analysis of A. brasiliensis KA21 for Safety
Assessment
Before starting animal and human experiments, the
chemical composition and additives were screened.
The chemical composition and nutrients are shown
in Table 1. Recently, a major toxic compound of
agaricaceae ‘agaritine’ has attracted attention by showing
tumor-promoting activity in rats. The agaritine content of
A. brasiliensis KA21 was measured and it was as low as
15.3ppm. Heavy metals, such as lead and mercury were
lower than the detection limit. Three hundred types of
pesticides were measured and none was detected (data
not shown).
b-glucan content of A. brasiliensis KA21 was
12.4g100g
 1 measured by Japan food research labora-
tories. We have already precisely examined the structure
of polysaccharide fractions of KA21, and the major
structure of b-glucan showing immunomodulating
activity was determined to be b-1,6-linked glucan with
highly branched b-1,3-segment (20).
Vitamin D is a well known vitamin of macrofungi and
KA21 contained 56.7mg100g
 1 (¼ca. 2250IU100g
 1).
Same strain, cultured inside the house did not contain
detectable concentration of vitamin D (data not shown).
It is well known that concentration of vitamin D is
strongly dependent on sunlight exposure. Vitamin D
content of KA21 well reflected the culture condition of
outdoor and under the sunlight.
From these data, A. brasiliensis KA21 was found to be
chemically and analytically safe for animal and human
studies.
Parameters and Effects on Experimental Animals
Effect on Normal Inbred Strains of Mice
For the animal experiments, AgCWE, AgHWE were
prepared and examined. When AgCWE or AgHWE was
administered orally at the dose of 20mg/mouse to
healthy mice (C3H/HeN) for 2 weeks, cell count in the
thymus was not changed (data not shown), but that in
the spleen was increased in the AgCWE group (Fig. 1).
Cells were doubly stained with CD4/CD8a, ab/g,o r
CD3/B220, and the ratios of cell populations were
calculated after measurement with a flow cytometer.
No notable changes were seen in the thymus (data not
shown), whereas the ratio of CD4
þ in the spleen was
increased significantly in the AgHWE group (Fig. 1).
Antitumor Activity of Orally Administered AgCWE
and AgHWE in Sarcoma 180 Transplanted Mice
We evaluated the antitumor effect of A. brasiliensis on
Sarcoma 180 solid tumor, which is the standard system to
measure antitumor effects in mice. Sonifilan (SPG) was
used as standard material. Oral administration of
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Figure 1. Cell number and population of splenocytes from AgHWE or CWE p.o. mice. AgHWE, CWE or saline (200ml/mouse, 1day, 1 shot), was
p.o. administered to C3H/HeN mice for 14 days. The splenocytes were collected from each group of mice on day 14. Total cell number was counted
with a hemocytometer (left). CD4/CD8a were measured by flow cytometory (right). The results represent the means S.D. *P50.05, **P50.01
compared with control by Student’s t-test.
208 Immunomodulation by Agaricus brasiliensisAgCWE or AgHWE for 35 days led to the suppression of
tumor growth (Table 2).
Protection against Concanavalin A-Induced Liver Injury
by Orally Administered AgCWE and AgHWE in Mice
The intravenous administration of Con A, a plant lectin,
triggers acute hepatopathy in mice. We administered oral
AgCWE or AgHWE as pretreatment, and then assessed
the effects of Con A on hepatopathy. When 200mlo f
AgCWE or AgHWE was administered for 7 days as
pretreatment, GOT was found to decrease significantly in
the AgCWE group. A similar trend was seen in the
AgHWE group. When the dose was increased to 600ml
and administration was continued for 7 days, the effect
became more notable (Fig. 2). GPT was decreased in a
similar manner (data not shown). Similar studies were
performed using different forms of administration and
several mouse lines, and all cases showed a decreasing
trend. Together, the results show that A. brasiliensis
KA21 protects mice from hepatic injury.
Protection of Multiple Organ Failure Induced
by Lipopolysaccharide by Oral Administration of
A. brasiliensis KA21
Next, we investigated cytokine production induced by the
administration of bacterial endotoxin, LPS, an agent that
induces multiple organ failure in severe infections, to
determine the hepatocellular protective effect of AgCWE
and AgHWE. The levels of TNF-a and IL-6 generated by
LPS administration were decreased in both groups
(Fig. 3), indicating that A. brasiliensis controls the level
of cytokine production to protect organs.
Table 2. Antitumor effect of A. brasiliensis extracts on solid form of
Sarcoma 180 in ICR mice
Name Dose
(mg)
Times Route CR/n Tumor weight
mean/SD (g)
%
Inhibition
t-test
Control 0/12 8.6 4.3 0.0
SPG 0.1 3 i.p. 7/11 0.4 1.1 95 50.001
Control 0/10 15.0 6.5 0
AgCWE 2 35 p.o. 0/10 9.6 6.5 36 50.05
AgHWE 2 35 p.o. 0/10 7.9 2.5 47 50.01
Note: Dose, per mouse; times, day 7, 9, 11; CR/n, Number of tumor
free mice/total mouse. SPG, Standard b-glucan as positive control.
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Figure 3. Effect of oral A. brasiliensis on LPS-induced cytokine production. b-Glucan (SCG, 200mg/mouse) was i.p. administered to Balb/c mice on
day 0. AgHWE or CWE was p.o. administered to these mice for 7 days. LPS (10mg/mouse) was iv administered as a triggering reagent on day 7 and
the sera were prepared 1.5h later from each group of mice. IL-6 and TNF-a was measured by ELISA. Results are expressed as the mean SD
*P50.05 compared with control by Student’s t-test. (left) TNF-a, (right) IL-6.
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Figure 2. Effect of AgCWE or HWE p.o. on Con A-Induced liver injury. (Left) AgHWE or CWE (200ml/mouse) was p.o. administered to Balb/c
mice for 7 days. Con A (20mgkg
 1) was iv administered on day 7 and the sera were prepared 24h later from each group of mice. Results are
expressed as the mean SD *P50.05 compared with control by Student’s t-test. (N¼7). (right) AgHWE or CWE (600ml/mouse) was p.o.
administered to Balb/c mice for 7 days. Con A (20mgkg
 1) was iv administered on day 7 and the sera were prepared 24h later from each group of
mice. Results are expressed as the mean SD ***P50.001 compared with control by Student’s t-test. (N¼3).
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Safety of A. brasiliensis
Before determining the safety of A. brasiliensis KA21,
a normal dose was administered for 3 months to 13 subjects
as a preliminary experiment and measured changes
of general clinical parameters. Mean body weight
(71.2!70.9kg), size of waist (85.4!83.5cm),
percentage body fat (34.4–33.0%) and BMI (27.8–27.6)
did not show any clinical sign of illness by taking it.
Thus to precisely determine the safety of A. brasiliensis
KA21, a dose of three times higher than the normal
dose was administered for 6 months to 11 subjects (group 1,
see ‘Methods’), and subjective changes in conditions, liver
function, renal function and nutritional conditions were
measured and analyzed. After measuring the biochemical
parameters, we confirmed no statistically significant
difference before and after administration, and no side
effects caused by long-term administration (Table 3).
Effect of A. brasiliensis on Biochemical Parameters related
to Adiposis and Diabetes
In order to evaluate the effect of A. brasiliensis KA21 on
lifestyle-related diseases, the normal dose was administered
to 12 subjects (group 2, see ‘Methods’) for 3 months
and comparison of clinical biochemical data was made.
Theresultsareasfollows:(i)Significantdecreaseswereseen
in body weight and BMI (P50.01 each) after administra-
tion (Figs 4 and 5). (ii) Significant decreases were observed
in percentage body fat (P50.01) and percentage visceral
fat (P50.01) after administration (Figs 6 and 7).
(iii) Significant increase was found in total protein level
(P50.03) after administration (Fig. 8). (iv) Significant
reduction was seen in blood glucose level (P50.02) after
administration (Fig. 9).
Table 3. Safety of A. brasiliensis KA21 in human volunteers
Biochemical
parameters
Before
(mean SD)
After
(mean SD)
Statistics
(P-value)
Total protein (gdl
 1) 7.50 0.16 7.41 0.25 0.31
BUN (mgdl
 1) 15.81 5.93 13.45 2.25 0.12
Creatinine (mgdl
 1) 0.92 0.21 0.90 0.20 0.19
GOT (ml
 1) 18.8 4.75 19.8 4.40 0.10
GPT (ml
 1) 15.7 6.90 16.3 4.90 0.52
g-GTP (ml
 1) 35.4 29.6GTP 35.9 30.1 0.89
(N¼11).
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Figure 4. Effect of A. brasiliensis on body weight. Experimental
protocol was shown in ‘Methods’.
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Figure 5. Effect of A. brasiliensis on BMI. Experimental protocol was
shown in ‘Methods’.
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Figure 6. Effect of A. brasiliensis on percentage body fat. Experimental
protocol was shown in ‘Methods’.
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Figure 7. Effect of A. brasiliensis on percentage visceral fat.
Experimental protocol was shown in ‘Methods’.
210 Immunomodulation by Agaricus brasiliensisIn order to analyze the data more precisely, the
subjects were divided according to total cholesterol level
into a normal value group (T-CHO5200mg/dl) and a
mibyou (slightly sick) value group (T-CHO 200mg/dl)
for comparison. No change was observed in the
T-CHO5200mg/dl group before and after adminis-
tration, whereas a decrease was seen in the
T-CHO 200mg/dl group after administration (Fig. 10).
The subjects were divided according to blood neutral
fat level into a normal value group (TG5120mg/dl)
and a mibyou value group (TG 120mg/dl) for
comparison. No change was observed in the former,
whereas a decrease was observed in the latter after
administration (Fig. 11).
Improvement of Liver Function by A. brasiliensis
To determine liver function, we compared GOT, GPT
and g-GTP values of the earlier mentioned subjects
shown in the previous section. When comparison was
made among all 12 subjects, no differences were seen
before and after administration (Fig. 12). By contrast,
after the subjects were divided into normal and mibyou
according to GOT level, the average value of GOT in the
normal value group (GOT525IUl
 1) was found to
increase slightly after administration, whereas that in the
mibyou value group (GOT 25IUl
 1) was found to
decrease after administration, although the difference was
not statistically significant (Fig. 13). The average value of
GPT was increased in the normal value group
(GPT525IUl
 1) after administration, whereas that in
the mibyou value group (GPT 25IUl
 1) was decreased
slightly after administration, the difference being not
statistically significant (Fig. 14). The average value of
g-GTP was decreased slightly in the normal value group
(g-GTP530IUl
 1) after administration, whereas that in
the mibyou value group (g-GTP 30IUl
 1) was almost
unchanged (Fig. 15).
Taken together, we determined that both lipid and
blood glucose levels showed a decreasing trend for
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Figure 8. Effect of A. brasiliensis on total protein level. Experimental
protocol was shown in ‘Methods’.
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Figure 9. Effect of A. brasiliensis on blood glucose level. Experimental
protocol was shown in ‘Methods’.
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Figure 10. Effect of A. brasiliensis on blood cholesterol level from the viewpoint of Mibyou. Experimental protocol was shown in ‘Methods’.
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Figure 11. Effect of A. brasiliensis on neutral fat level from the viewpoint of Mibyou. Experimental protocol was shown in ‘Methods’.
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Figure 12. Effect of A. brasiliensis on liver function. Experimental protocol was shown in ‘Methods’.
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Figure 13. Effect of A. brasiliensis on liver function (GOT Value) from the viewpoint of mibyou. Experimental protocol was shown in ‘Methods’.
212 Immunomodulation by Agaricus brasiliensislifestyle-related diseases. In addition, an improvement in
liver function was noted.
Modulation of Natural Killer Cell by A. brasiliensis
In order to evaluate the effect of A. brasiliensis KA21 on
immune function, NK cell number and function were
examinedbyeightsubjectsinadouble-blindedexperimental
protocol shown in ‘Methods’ (group 3, see ‘Methods’).
The normal dose or placebo was administered to
eight subjects for 7 days and NK cell number and activity
in peripheral blood was compared as follows.
Effect of A. brasiliensis on NK Cell Count
Comparison of NK cell count before and after admin-
istration, and comparison between the A. brasiliensis
group and placebo group were made, and no statistically
significant differences were observed (Fig. 16).
Augmentation of NK Cell Activity by A. brasiliensis KA21
Before administration, no significant differences were
observed between A. brasiliensis group and placebo group
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Figure 14. Effect of A. brasiliensis on liver function (GPT Value) from the viewpoint of mibyou. Experimental protocol was shown in ‘Methods’.
0
20
40
60
80
100
120
0
5
10
15
20
25
30
(IUl−1) (IUl−1)
γ-GTP<30 IUl−1 (N=5) γ-GTP≥30 IUl−1 (N=7)
Before After Before After
Figure 15. Effect of A. brasiliensis on liver function (g-GTP Value) from the viewpoint of mibyou. Experimental protocol was shown in ‘Methods’.
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Figure 16. Comparison of NK cell count between groups before and
after administration of A. brasiliensis. Experimental protocol was shown
in ‘Methods’.
eCAM 2008;5(2) 213(Fig. 17 left). After administration, there were significant
differences between the two groups, with P50.01 for the
E/T¼20% group and P50.001 for the E/T¼10% group
(Fig. 17 right). Figs 18 and 19 show individual changes in
NK cell activity after administration of A. brasiliensis
(Fig. 18) and placebo (Fig. 19) groups. NK cell activity
was increased significantly in A. brasiliensis groups, with
P50.001 for the E/T¼20% group and P50.001 for the
E/T¼10% group. Meanwhile, NK cell activity was not
increased significantly in the placebo group after
administration.
Discussion
Japan is rapidly becoming a super-aging society, and
such issues as decreased workforce, consumption and
tax revenues, and increased international competition
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Figure 17. Effect of A. brasiliensis on NK cell activity. (Comparison between A. blazei group and placebo group). Experimental protocol was shown
in ‘Methods’.
E/T=20 E/T=10
10
15
20
25
30
35
40
P < 0.001 P < 0.001
0
5
10
15
20
25
30
Before After Before After
A
c
t
i
v
i
t
y
 
o
f
 
N
K
 
c
e
l
l
s
 
(
%
)
A
c
t
i
v
i
t
y
 
o
f
 
N
K
 
c
e
l
l
s
 
(
%
)
Figure 18. Comparison of NK cell activity before and after administration of A. brasiliensis. Experimental protocol was shown in ‘Methods’.
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Figure 19. Comparison of NK cell activity before and after administration of placebo. Experimental protocol was shown in ‘Methods’.
214 Immunomodulation by Agaricus brasiliensisamong neighboring Asian nations are emerging. As a
dramatic increase in the number of elderly patients is
inevitable, the social security system is expected to
become financially strained, and patient and consumer
awareness of their rights will be enhanced because of the
increased financial burden levied on them. Whereas
genetic disposition is said to be involved in the
development of lifestyle-related conditions and diseases,
such as diabetes, hyperlipidemia and cancer, several other
factors also determine their development; therefore,
lifestyle is closely related to the development of such
conditions and diseases. On the other hand, there is a
need to reduce the significantly elevated medical expenses
in the future. There are discussions as to whether we
should pay medical expenses to aid people who do not
practice a healthy lifestyle. The number of people who
are not sick yet not healthy, that is, ‘in poor health’ or
‘mibyou’, is increasing at an accelerated pace (27,28). It is
difficult to maintain regular eating habits in stress-laden
daily life. Improvement of diet by consuming functional
foods seems to contribute to the health improvement of
people with poor health, as well as to the prevention of
the development of lifestyle-related diseases.
There are many functional foods in Japan and they are
expensive for customers, thus accurate information is
needed to select the best food for each customer. All the
parameters of safety, cost performance, evidence of
function, as well as taste are important to disclose.
Mushrooms have been a part of oriental medicine for
hundreds of years as being beneficial for health. Most
traditional knowledge about the medicinal properties of
mushrooms comes from the Far East, Japan, China,
Korea and Russia. The most striking evidence is that
lentinan from L. edodes, sonifilan from Schizophyllum
commune and krestin from Coriorus versicolor have been
approved for anticancer drugs mediated by immune
stimulation. A great many mushroom products are on
the market as health promoting foods, and basic and
clinical researches of these products have been performed
continuously (29–41).
Currently, there are 80000 known fungal species in the
world. It is surmised that 1500000 species exist, including
undiscovered species. These fungi are classified by king-
dom, phylum/division, class, genus and species. Many
fungi are classified into Basidiomycota or Ascomycota,
whereas others are also classified into the kingdom
Protozoa or kingdom Chromista. Fungi include mush-
rooms, molds and yeasts, which have significantly
different appearance and sizes. As mushrooms are too
large to be considered microorganisms, they are referred
to as macrofungi. Lichens of which two or more
microorganisms live in a symbiotic relationship are also
included. Fungi exhibit both the sexual form (for
example, morphology of mushroom) and the asexual
form for regeneration (for example, morphology of
mycelium) and either form is used depending on
surrounding environmental changes; however, the exis-
tence of both forms (holomorph) is not known for all
fungi. Their nomenclature is also characteristic. The
background of the discovery of a fungus is reflected in its
name and different names may be given depending on
whether the fungus exhibits the sexual form (teleomorph)
or the asexual form (anamorph) of regeneration. Fungi,
particularly mushrooms, are ‘cultivated’ and distributed
products, and detailed analysis of their components has
been performed. In the Standard Tables of Food
Composition in Japan (Fifth Edition), 36 foods are
classified as ‘mushrooms’. The representative nutritional
composition of mushrooms includes fiber, glucose and
sugar alcohols, organic acids, fatty acids, inorganic
substances, vitamins, free amino acids, bitter and pungent
components, flavor components, enzymes, biophylactic
substances, pharmacologically active substances and toxic
components. Moreover, molds and yeasts are related to
some fermented foods. A variety of foods including sake
(rice wine), miso (bean paste), soy sauce, cheese and
katsuobushi (dried bonito) are manufactured with the
help of eukaryotic microorganisms. Fungus produces
many secondary metabolites that are used as drugs or
raw material for drugs, an example of which is penicillin.
As regards edible mushrooms, some are consumed raw,
and cultivated hypha and culture broth are distributed as
supplements after processing. Although they are from the
same fungus, there is no proof that they contain the same
components as the cultivated fruit bodies. In the early
1980s, we performed animal studies to compare the
macromolecular components of G. frondosa fruit bodies,
mycelia and fermented products. That the quantities and
quality of components contained in each extract differed
considerably was also reflected in the activity (29–32).
Grifola frondosa has been well studied in Japan and in
other countries. Interestingly, the major active compo-
nent differs depending on the study group (33–37).
Comparing mushrooms and mycelia at the product
level, it was found that live fungus differs from dried
products. From the viewpoint of stable supply, the dried
product is desirable, but its components change accord-
ing to the drying method. It is likely that the components
differ if the ‘fungal strain’ differs. Thus, one type of
mushroom may vary greatly when processed as food or
other products. When we want to discuss or evaluate
components and pharmacologic action, we need to
conduct comparisons under detailed conditions, especially
if we perform animal experiments.
Agaritine (N-[g-L-(þ)-glutamyl]-4-hydroxymethylphe-
nylhydrazine) was identified in fruit bodies of cultivated
mushrooms belonging to the genus Agaricus, including
commerce A. bisporus and closely related species (42–46).
4-(hydroxymethyl) benzenediazonium ion that had
mutagenicity is believed to be formed when agaritine
is metabolized. Agaritine is most prevalent, usually
occurring in quantities between 200 and 400mgg
 1 as
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 1 as dry weight in culti-
vated mushroom. Recently, agaritine in A. brasiliensis
(A. blazei) sample and products was measured. These
samples contained 112–1791mgg
 1 of agaritine as dry
weight (47). In the present study, we have detected only
low concentrations of agaritine (15.3ppm; 15.3mgg
 1)
in the preparation made of A. brasiliensis KA21. This
value was 51/100 of the quantity of average values of
A. bisporus. Agaritine content is known to be significantly
varied depending on processing. Household processing
(e.g. boiling, frying, microwave heating or drying) will
reduce the agaritine content in A. bisporus by up to 50%
or even more (48). Also, agaritine has recently been
shown to be degraded oxygen dependent in water
(42,43). There have been long discussing the toxicity
and carcinogenicity of agaritine (44,45). However, the
conclusion is still controversial. Toth and co-workers
(46,49–51) undertook the work to assess the possible
carcinogenic activity of the phenylhydrazines and related
compounds in A. bisporus. Their studies indicated
that most of phenylhydrazine and related compounds in
the mushroom are carcinogenic in Swiss albino mice. The
only compound that was tested negative was agaritine,
a finding that significantly muddled the interpretation
of the carcinogenicity data. Also, these studies were the
conservative risk model. In the absence of epidemiologi-
cal data, no evaluation of carcinogenicity of agaritine to
humans could be made.
We have analyzed A. brasiliensis KA21 from various
aspects and reported the b-glucan, the enzymes
of polyphenol oxidase, peroxidase and b-1,3-Glucanase.
b-glucan content of A. brasiliensis KA21 was
12.4g100g
 1 measured by Japan food research labora-
tories. We have already precisely examined the structure
of polysaccharide fractions of KA21, and the major
structure of b-glucan showing immunomodulating
activity was determined to be b-1,6-linked glucan with
highly branched b-1,3-segment (20). During that study
we have prepared hot water extract, cold alkaline extract,
and hot alkaline extracts and analyzed polysaccharide
structure of all these fractions. Of much interest, all the
fraction showed quite similar structural features that
major linkage is b-1,6-linked glucan. From these data,
major polysaccharide component in A. brasiliensis is b-1,
6-linked glucan, and it is consistent with the previous
study. However, we have mentioned that antitumor
activity needs b-1,3-linkages in addition to b-1,6-linkage
based on the results of the limited chemical degradation
study. However, this conclusion is still temporal and
structural activity relations needed human studies.
This study showed that the fungus is rich in vitamins;
as it is cultured outdoors, it contains detectable
concentrations of vitamin D. Vitamin D is a well-
known vitamin of macrofungi and KA21 contained
56.7mg100g
 1 dry weight. In the parallel experiments,
vitamin D was contained lower than the detection limit
(0.7mg100g
 1) in the mycelium of this fungi cultured in
the liquid medium and the fruit body of A. blazei
imported from China. Much differences of vitamin D in
these products well reflected the culture condition of
outdoors and under the sunlight. Relationship between
vitamin D content and sunlight exposure has been
demonstrated in various macrofungi (52). Based on the
definition in the manual of Health Food Regulation in
Japan, the food containing more than 1.5mg100g
 1
(¼60IU100g
 1) of vitamin D is defined as the food
containing high vitamin D content. Considering the rule,
KA21 is the food containing high concentration of
vitamin D. Micronutrients such as vitamins and minerals
promote the metabolism of waste products, carbohy-
drates and lipids via cellular activation, and improved
insulin resistance by decreasing blood glucose. Fiber
and unsaturated fatty acids decrease blood pressure and
promote decholesterolization. KA21 also contained
other micronutrients, thus it is good for health for
variety of reasons.
Meanwhile, in an analysis of the active components in
bupleurum root, a crude drug, we found that polyphenols
polymerized by enzymes have a strong immunoenhancing
effect (53–55). A. brasiliensis also has a number of
enzymes related to the polymerization of polyphenols
(23,24). Polyphenols polymerized by these enzymes may
be active components in this fungus. In our clinical
research, decreases in body weight, BMI, percentage
body fat, percentage visceral fat and blood glucose level
were noted and a tendency to decrease blood cholesterol
level, blood neutral fat level, GOT, GPT and g-GTP was
observed in the mibyou value group. On the basis of the
earlier results, among the components of this fungus, all
the polysaccharides, enzymes, vitamins and minerals may
be involved in the normalization of biochemical test
results.
This study measured immune function in mice.
When we compared the number and population of
immunocompetent cells after administration of AgCWE
or AgHWE to healthy mice orally for 2 weeks, it was
found that the percentage of spleen CD4
þT cells was
increased in the AgHWE group and the number of spleen
cells was increased in the AgCWE group. Furthermore,
both AgCWE and AgHWE showed antitumor effects and
AgCWE prevented Con A-induced hepatopathy and
suppressed cytokine production induced by LPS.
CD4
þT cells are divided into type 1 helper T cells
(Th1) and type 2 helper T cells (Th2) based on T-cell
antigen stimulation, and Th1 is considered to be a more
important contributor to the antitumor effect. Th1 is
thought to infiltrate local sites well, demonstrate strong
cytotoxicity and cytokine production ability, and induce
complete tumor regression by locally inducing CTL,
which has the ability to produce IFN-g (56–58).
It is likely that the antitumor effect of A. brasiliensis
is closely related to the increase in CD4
þT cell count.
216 Immunomodulation by Agaricus brasiliensisAs changes in immunocytes were demonstrated by the
oral administration of A. brasiliensis in healthy mice, it is
expected that the daily intake of A. brasiliensis may have
preventive effects on immunoregulation failure.
Agaricus brasiliensis suppressed organ dysfunction
accompanied by blood with excessively high cytokine
levels, which is related to multiple organ failure. It is
desirable that cytokines be produced at certain levels as
needed. In these models, such as LPS-elicited cytokine
production, A. brasiliensis controlled excessive cytokine
production (Fig. 3). A. brasiliensis can not only promote
but also control immunity, which is considered a
desirable effect.
Among the effects of A. brasiliensis on immune
function, we examined changes in the ratio of NK cells
to peripheral mononuclear cells and NK cell activity in
humans. Both the A. brasiliensis group and the placebo
group showed no significant changes in the ratio and
number of NK cells to peripheral mononuclear cells after
1-week administration. On the other hand, comparing
the A. brasiliensis and placebo groups, NK cell activity
was significantly enhanced by the administration of
A. brasiliensis. When individual cases were examined,
almost all cases showed increasing NK cell activity with
the administration of A. brasiliensis, although there were
differences in the degree of increase (Fig. 18).
The measurement of NK cell activity has been most
widely used in both animal and human experiments,
because NK cells play a critical role in natural
immunology, and measurement of cytotoxicity is reliable
for evaluation with good reproducibility (5). The immune
function is affected by NK cells as well as various
lymphocyte and humoral factors including antibodies,
complement and cytokines. There have been several
publications demonstrating products of macrofungi
enhanced NK activity (59–63).
The effect of A. brasiliensis on the degree of NK
cell activity enhancement varied significantly among
individuals. It was recently clarified that effectiveness as
well as the appearance of side effects with each
medication were significantly different in each individual.
This is explained partly by polymorphism and the link-
age of CYP-related genes, a drug-metabolizing enzyme
group (64,65). On the other hand, many causative genes
have been discovered in immunity-related diseases, some
of which are polymorphic. It is possible that polymorph-
ism may be related to individual differences observed
in the effects of A. brasiliensis. Research into receptors
for mushroom components is not extensive. Dectin-1
was recently determined to be the receptor for cell wall
b-glucan, a major component of mushrooms (66–68).
The relationship between polymorphism of the receptor
for pathogens and disease has been elucidated (69,70).
The effects of A. brasiliensis and receptor gene poly-
morphism may be related. Further analysis is necessary in
the future.
Through basic and clinical research, we confirmed
that A. brasiliensis can help to improve symptoms of
lifestyle-related diseases because of its anti-inflammatory,
antitumor and immunoenhancing effects, and that
A. brasiliensis is a useful health food to treat mibyou
(primary prevention).
Very recently we have experienced recall of one health
food originated from A. brazei, because of inducing
genotoxicity in experimental animals. Ministry of Health,
Labor and Welfare reported it is only the case of one
product and the molecular mechanisms are under
investigation. Based on the clinical examination shown
in this study, KA21 is very safe for human health. Any
adverse effect could not be detected in our study.
We have also stated that content as well as pharmaco-
logical action is significantly influenced by culture
conditions even in the same fungi, such as vitamin D
content. In addition, proteins may be decomposed during
processing. Much restricted regulation for each of the
health foods might be needed for increasing human
health. In any case, agaricaceae contained many species
for functional foods, thus, much study should be needed
continuously. This study helped to understand the
mushrooms of agaricaceae are very safe and useful for
human health.
Conclusion
(i) In basic research using a mouse model, we
determined that A. brasiliensis has antitumor,
anti-inflammatory and hepatocellular protective
effects. It was suggested that the increase in the
number of helper T cells and the enhancement of
NK cell activity are related to these effects.
(ii) In clinical research on human volunteers, we found
that A. brasiliensis decreased body weight, BMI,
percentage body fat, percentage visceral fat and
blood glucose level significantly, and reduced
obesity. It also decreased blood cholesterol level
and neutral fat level, normalized liver function and
activated the immune function in mibyou patients
(people with poor health).
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